| Insideraktier | 47.889.840 shares |
Insider-stemningsscore
Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.
Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.
Officers sentiment score
Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.
Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.
Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.
Nøgle Insider Metrics
Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.
For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).
Netto antal insidere, der køber (rang)
N/A
Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).
Procent af float købt af insidere (rangering)
N/A
Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.
Insiderhandelsdiagram
Timber Pharmaceuticals Inc insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.
Insiderliste og lønsomhedsmålinger
Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.
See our leaderboard of most profitable insider traders.
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|
Report errors via our new Insider Auditing Tool
Track Records af insiderkøb - Kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i TMBR / Timber Pharmaceuticals Inc. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Track Records af insidersalg - Kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i TMBR / Timber Pharmaceuticals Inc. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Transaktionshistorik
Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.
| Fil Dato |
Handle Dato |
Form | Insider | Ticker | Sikkerhedstitel | Kode | Direkte | Dyrke motion Pris |
Enhed Pris |
Enheder Ændret |
Værdi Ændret (1K) |
Tilbage Muligheder |
Tilbage Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-08-22 | 2023-08-20 | 4 | Koconis John | TMBR | Common Stock, par value $0.001 per share | D | 70.385 | 70.785 | ||||||
| 2023-08-22 | 2023-08-20 | 4 | Mendelsohn Alan | TMBR | Common Stock, par value $0.001 per share | D | 35.193 | 35.393 | ||||||
| 2023-08-22 | 2023-08-20 | 4 | Lucchese Joseph | TMBR | Common Stock, par value $0.001 | D | 35.193 | 35.193 | ||||||
| 2023-04-18 | 2023-04-15 | 4 | Gaal Lubor | TMBR | Common Stock, par value $0.001 per share | D | 4.100 | 6.100 | ||||||
| 2023-04-18 | 2023-04-15 | 4 | Pirozzi Gianluca | TMBR | Common Stock, par value $0.001 per share | D | 4.100 | 6.100 | ||||||
| 2023-04-18 | 2023-04-15 | 4 | Sitar Edward J | TMBR | Common Stock, par value $0.001 per share | D | 5.327 | 11.127 | ||||||
| 2023-04-18 | 2023-04-15 | 4 | Cohen David E | TMBR | Common Stock, par value $0.001 per share | D | 4.100 | 6.100 | ||||||
| 2022-12-16 | 2022-12-15 | 4 | Sitar Edward J | TMBR | Common Stock, par value $0.001 per share | D | 1,6290 | 2.500 | 4 | 5.800 | ||||
| 2022-04-19 | 2022-04-15 | 4 | Lucchese Joseph | TMBR | Stock Option (right to buy) | D | 0,31 | 300.000 | 300.000 | |||||
| 2022-04-19 | 2022-04-15 | 4 | Mendelsohn Alan | TMBR | Stock Option (right to buy) | D | 0,31 | 300.000 | 300.000 | |||||
| 2022-04-19 | 2022-04-15 | 4 | Koconis John | TMBR | Stock Option (right to buy) | D | 0,31 | 600.000 | 600.000 | |||||
| 2022-04-19 | 2022-04-15 | 4 | Cohen David E | TMBR | Stock Option (right to buy) | D | 0,31 | 100.000 | 100.000 | |||||
| 2022-04-19 | 2022-04-15 | 4 | Cohen David E | TMBR | Common Stock, par value $0.001 per share | D | 100.000 | 100.000 | ||||||
| 2022-04-19 | 2022-04-15 | 4 | Sitar Edward J | TMBR | Stock Option (right to buy) | D | 0,31 | 150.000 | 150.000 | |||||
| 2022-04-19 | 2022-04-15 | 4 | Sitar Edward J | TMBR | Common Stock, par value $0.001 per share | D | 150.000 | 165.000 | ||||||
| 2022-04-19 | 2022-04-15 | 4 | Pirozzi Gianluca | TMBR | Stock Option (right to buy) | D | 0,31 | 100.000 | 100.000 | |||||
| 2022-04-19 | 2022-04-15 | 4 | Pirozzi Gianluca | TMBR | Common Stock, par value $0.001 per share | D | 100.000 | 100.000 | ||||||
| 2022-04-19 | 2022-04-15 | 4 | Gaal Lubor | TMBR | Stock Option (right to buy) | D | 0,31 | 100.000 | 100.000 | |||||
| 2022-04-19 | 2022-04-15 | 4 | Gaal Lubor | TMBR | Common Stock, par value $0.001 per share | D | 100.000 | 100.000 | ||||||
| 2022-04-15 | 2022-03-04 | 4 | Rome Zachary | TMBR | Value Appreciation Rights | D | 0,01 | 79.326 | 0 | |||||
| 2022-04-15 | 2022-03-04 | 4 | Rome Zachary | TMBR | Value Appreciation Rights | D | 0,01 | -52.884 | 79.326 | |||||
| 2022-04-15 | 2022-03-04 | 4 | Rome Zachary | TMBR | Common Stock, par value $0.001 per share | D | 0,2800 | -19.630 | -5 | 59.696 | ||||
| 2022-04-15 | 2022-03-04 | 4 | Rome Zachary | TMBR | Common Stock, par value $0.001 per share | D | 0,0100 | 79.326 | 1 | 79.326 | ||||
| 2021-12-16 | 2021-12-15 | 4 | Koconis John | TMBR | Common Stock, par value $0.001 per share | D | 0,3843 | 20.000 | 8 | 20.000 | ||||
| 2021-11-24 | 2021-11-23 | 4 | Mendelsohn Alan | TMBR | Common Stock, par value $0.001 per share | D | 0,4700 | 10.000 | 5 | 10.000 | ||||
| 2021-11-24 | 2021-11-23 | 4 | Sitar Edward J | TMBR | Common Stock, par value $0.001 per share | D | 0,4600 | 15.000 | 7 | 15.000 | ||||
| 2021-09-29 | 2021-09-27 | 4 | Lucchese Joseph | TMBR | Stock Option (right to buy) | D | 0,92 | 361.163 | 361.163 | |||||
| 2021-09-16 | 2021-09-14 | 4 | Rome Zachary | TMBR | Stock Option (right to buy) | D | 0,89 | 561.000 | 561.000 | |||||
| 2021-09-16 | 2021-09-14 | 4 | Koconis John | TMBR | Stock Option (right to buy) | D | 0,89 | 890.000 | 890.000 | |||||
| 2021-09-02 | 2021-09-02 | 4 | TardiMed Sciences LLC | TMBR | Common Stock, par value $0.001 per share | D | 0,9376 | -225.000 | -211 | 3.508.567 | ||||
| 2021-09-01 | 2021-09-01 | 4 | TardiMed Sciences LLC | TMBR | Common Stock, par value $0.001 per share | D | 0,9227 | -150.500 | -139 | 3.733.567 | ||||
| 2021-09-01 | 2021-08-31 | 4 | TardiMed Sciences LLC | TMBR | Common Stock, par value $0.001 per share | D | 0,9116 | -150.000 | -137 | 3.884.067 | ||||
| 2021-09-01 | 2021-08-30 | 4 | TardiMed Sciences LLC | TMBR | Common Stock, par value $0.001 per share | D | 0,9266 | -100.000 | -93 | 4.034.067 | ||||
| 2021-08-26 | 2021-08-26 | 4 | TardiMed Sciences LLC | TMBR | Common Stock, par value $0.001 per share | D | 0,9184 | -100.000 | -92 | 4.134.067 | ||||
| 2021-08-26 | 2021-08-25 | 4 | TardiMed Sciences LLC | TMBR | Common Stock, par value $0.001 per share | D | 0,9126 | -100.000 | -91 | 4.234.067 | ||||
| 2021-08-26 | 2021-08-24 | 4 | TardiMed Sciences LLC | TMBR | Common Stock, par value $0.001 per share | D | 0,9253 | -100.000 | -93 | 4.334.067 | ||||
| 2021-08-20 | 2021-08-20 | 4 | TardiMed Sciences LLC | TMBR | Common Stock, par value $0.001 per share | D | 0,9079 | -50.000 | -45 | 4.434.067 | ||||
| 2021-08-20 | 2021-08-19 | 4 | TardiMed Sciences LLC | TMBR | Common Stock, par value $0.001 per share | D | 0,9540 | -50.000 | -48 | 4.484.067 | ||||
| 2021-08-20 | 2021-08-18 | 4 | TardiMed Sciences LLC | TMBR | Common Stock, par value $0.001 per share | D | 1,0010 | -75.000 | -75 | 4.534.067 | ||||
| 2021-07-06 | 2021-07-01 | 4 | Mendelsohn Alan | TMBR | Stock Option (right to buy) | D | 1,18 | 347.991 | 347.991 | |||||
| 2021-07-06 | 2021-07-01 | 4 | Pirozzi Gianluca | TMBR | Stock Option (right to buy) | D | 1,18 | 47.623 | 47.623 | |||||
| 2021-07-06 | 2021-07-01 | 4 | Sitar Edward J | TMBR | Stock Option (right to buy) | D | 1,18 | 47.623 | 47.623 | |||||
| 2021-07-06 | 2021-07-01 | 4 | Cohen David E | TMBR | Stock Option (right to buy) | D | 1,18 | 71.893 | 71.893 | |||||
| 2021-07-06 | 2021-07-01 | 4 | Gaal Lubor | TMBR | Stock Option (right to buy) | D | 1,18 | 71.893 | 71.893 | |||||
| 2021-06-15 | 2021-06-15 | 4 | TardiMed Sciences LLC | TMBR | Common Stock, par value $0.001 per share | D | 1,2627 | -28.450 | -36 | 4.609.067 | ||||
| 2021-06-15 | 2021-06-14 | 4 | TardiMed Sciences LLC | TMBR | Common Stock, par value $0.001 per share | D | 1,2669 | -146.465 | -186 | 4.637.517 | ||||
| 2021-06-10 | 2021-06-10 | 4 | TardiMed Sciences LLC | TMBR | Common Stock, par value $0.001 per share | D | 1,2629 | -185.229 | -234 | 4.783.982 | ||||
| 2021-06-10 | 2021-06-09 | 4 | TardiMed Sciences LLC | TMBR | Common Stock, par value $0.001 per share | D | 1,2739 | -96.481 | -123 | 4.969.211 | ||||
| 2021-06-10 | 2021-06-08 | 4 | TardiMed Sciences LLC | TMBR | Common Stock, par value $0.001 per share | D | 1,2875 | -305.540 | -393 | 5.065.692 | ||||
| 2021-06-02 | 2021-06-02 | 4 | TardiMed Sciences LLC | TMBR | Common Stock, par value $0.001 per share | D | 1,2600 | -9.879 | -12 | 5.371.232 | ||||
| 2021-06-02 | 2021-06-01 | 4 | TardiMed Sciences LLC | TMBR | Common Stock, par value $0.001 per share | D | 1,2632 | -8.670 | -11 | 5.381.111 | ||||
| 2021-06-02 | 2021-05-28 | 4 | TardiMed Sciences LLC | TMBR | Common Stock, par value $0.001 per share | D | 1,2699 | -47.736 | -61 | 5.389.781 | ||||
| 2021-05-13 | 2021-03-03 | 4 | Mendelsohn Alan By spouse | TMBR | Common Stock, par value $0.001 per share | I | 2,1700 | 1.988 | 4 | 1.988 | ||||
| 2020-09-16 | 2020-09-16 | 4 | TardiMed Sciences LLC | TMBR | Common Stock, par value $0.001 per share | D | 1,0298 | -100.694 | -104 | 5.437.517 | ||||
| 2020-09-16 | 2020-09-15 | 4 | TardiMed Sciences LLC | TMBR | Common Stock, par value $0.001 per share | D | 1,0286 | -87.060 | -90 | 5.538.211 | ||||
| 2020-09-16 | 2020-09-14 | 4 | TardiMed Sciences LLC | TMBR | Common Stock, par value $0.001 per share | D | 1,0300 | -455 | -0 | 5.625.271 | ||||
| 2020-09-14 | 2020-09-11 | 4 | TardiMed Sciences LLC | TMBR | Common Stock, par value $0.001 per share | D | 1,0303 | -7.483 | -8 | 5.625.726 | ||||
| 2020-09-14 | 2020-09-10 | 4 | TardiMed Sciences LLC | TMBR | Common Stock, par value $0.001 per share | D | 1,0436 | -32.943 | -34 | 5.633.209 | ||||
| 2020-06-09 | 2020-06-08 | 4 | BROENNIMAN LINDA A | TMBR | Stock Option (right to buy) | D | 2,87 | 24.270 | 24.270 | |||||
| 2020-06-09 | 2020-06-08 | 4 | Stocum Michael | TMBR | Stock Option (right to buy) | D | 2,87 | 24.270 | 24.270 | |||||
| 2020-06-09 | 2020-06-08 | 4 | Lucchese Joseph | TMBR | Stock Option (right to buy) | D | 2,87 | 97.083 | 97.083 | |||||
| 2020-06-09 | 2020-06-08 | 4 | Pirozzi Gianluca | TMBR | Stock Option (right to buy) | D | 2,87 | 24.270 | 24.270 | |||||
| 2020-06-09 | 2020-06-08 | 4 | Sitar Edward J | TMBR | Stock Option (right to buy) | D | 2,87 | 24.270 | 24.270 | |||||
| 2020-06-09 | 2020-06-08 | 4 | Bragg Kimberly | TMBR | Stock Option (right to buy) | D | 2,87 | 38.833 | 38.833 | |||||
| 2020-05-20 | 2020-05-18 | 4 | Koconis John | TMBR | Value Appreciation Rights | D | 0,01 | 209.646 | 209.646 | |||||
| 2020-05-20 | 2020-05-18 | 4 | Rome Zachary | TMBR | Value Appreciation Rights | D | 0,01 | 132.209 | 132.209 | |||||
| 2020-05-20 | 2020-05-18 | 4 | Tavakkol Amir | TMBR | Value Appreciation Rights | D | 0,01 | 8.184 | 8.184 | |||||
| 2020-05-20 | 2020-05-18 | 4 | TardiMed Sciences LLC | TMBR | Series A Preferred Stock | D | 1.821 | 1.821 | ||||||
| 2020-05-20 | 2020-05-18 | 4 | TardiMed Sciences LLC | TMBR | Common Stock, par value $0.001 per share | D | 5.666.152 | 5.666.152 | ||||||
| 2020-02-12 | 2020-02-10 | 4 | Timber Pharmaceuticals LLC | BPMX | Common Stock, par value $0.01 per share | D | 0,0100 | -55.008 | -1 | 2.200.328 | ||||
| 2020-02-12 | 2020-02-10 | 4 | Timber Pharmaceuticals LLC | BPMX | Common Stock, par value $0.01 per share | D | 0,0100 | 2.255.336 | 23 | 2.255.336 | ||||
| 2020-02-12 | 2020-02-10 | 4 | TardiMed Sciences LLC | BPMX | Warrant (right to buy) | I | 0,01 | -2.225.336 | 0 | |||||
| 2020-02-12 | 2020-02-10 | 4 | TardiMed Sciences LLC | BPMX | Common Stock, par value $0.01 per share | I | 0,0100 | -55.008 | -1 | 2.200.328 | ||||
| 2020-02-12 | 2020-02-10 | 4 | TardiMed Sciences LLC | BPMX | Common Stock, par value $0.01 per share | I | 0,0100 | 2.255.336 | 23 | 2.255.336 | ||||
| 2019-07-18 | 2019-07-16 | 4 | Bosacki Steven | BPMX | Option to purchase common stock | D | 0,44 | 0,4400 | 91.000 | 40 | 91.000 | |||
| 2019-07-18 | 3 | Bosacki Steven | BPMX | No securities beneficially owned | D | 0 | ||||||||
| 2019-06-27 | 2019-06-25 | 4 | Vivo Capital VIII, LLC | BPMX | Common Stock | I | 1,0200 | -327.870 | -334 | 317.270 | ||||
| 2019-06-14 | 2019-06-12 | 4 | Goto Joyce | BPMX | Option to purchase common stock | D | 0,84 | 0,8400 | 70.000 | 59 | 70.000 | |||
| 2019-06-14 | 2019-06-12 | 4 | Tierney David S | BPMX | Option to purchase common stock | D | 0,84 | 0,8400 | 360.000 | 302 | 360.000 | |||
| 2019-06-14 | 2019-06-12 | 4 | Chan Kin Foong | BPMX | Option to purchase common stock | D | 0,84 | 0,8400 | 77.100 | 65 | 77.100 | |||
| 2019-06-14 | 2019-06-12 | 4 | Morlock Stephen | BPMX | Option to purchase common stock | D | 0,84 | 0,8400 | 32.700 | 27 | 32.700 | |||
| 2019-06-14 | 2019-06-12 | 4 | Plott Ronald Todd | BPMX | Option to purchase common stock | D | 0,84 | 0,8400 | 32.700 | 27 | 32.700 | |||
| 2019-06-14 | 2019-06-12 | 4 | Hubbard Michael | BPMX | Option to purchase common stock | D | 0,84 | 0,8400 | 32.700 | 27 | 32.700 | |||
| 2019-02-21 | 2019-02-01 | 4 | Plott Ronald Todd | BPMX | Option to purchase common stock | D | 0,20 | 0,2000 | 51.000 | 10 | 418.000 | |||
| 2019-02-21 | 2019-02-01 | 4 | Plott Ronald Todd | BPMX | Option to purchase common stock | D | 0,20 | 0,2000 | 34.000 | 7 | 367.000 | |||
| 2019-02-21 | 2019-02-01 | 4 | Plott Ronald Todd | BPMX | Option to purchase common stock | D | 0,11 | 0,1100 | 200.000 | 22 | 333.000 | |||
| 2019-02-21 | 2019-02-01 | 4 | Plott Ronald Todd | BPMX | Option to purchase common stock | D | 0,11 | 0,1100 | 133.000 | 15 | 133.000 | |||
| 2019-02-21 | 3 | Plott Ronald Todd | BPMX | No securities beneficially owned | D | 0 | ||||||||
| 2019-01-25 | 2019-01-23 | 4 | Krammer Anja B | BPMX | Common stock | D | 0,1100 | -115.874 | -13 | 1.884.126 | ||||
| 2018-10-31 | 2018-10-30 | 4 | Goto Joyce | BPMX | Option to purchase common stock | D | 0,20 | 0,2000 | 77.000 | 15 | 77.000 | |||
| 2018-10-31 | 2018-10-30 | 4 | Goto Joyce | BPMX | Option to purchase common stock | D | 0,17 | 0,1700 | 470.000 | 80 | 470.000 | |||
| 2018-10-22 | 2018-10-22 | 4 | Morlock Stephen By Stephen W. Morlock and Karen R. Morlock TTE UDT dated 04/21/03 | BPMX | Common stock | I | 0,1800 | -251.071 | -45 | 0 | ||||
| 2018-10-22 | 2018-10-22 | 4 | Morlock Stephen | BPMX | Common stock | D | 0,1800 | -220.766 | -40 | 0 | ||||
| 2018-10-22 | 2018-10-19 | 4 | Morlock Stephen | BPMX | Common stock | D | 0,1800 | -214.091 | -39 | 220.766 | ||||
| 2018-10-22 | 2018-10-18 | 4 | Morlock Stephen | BPMX | Common stock | D | 0,1900 | -439.099 | -83 | 434.857 | ||||
| 2018-10-12 | 2018-10-12 | 4 | Krammer Anja B | BPMX | Common stock | D | 0,1900 | -297.500 | -57 | 2.000.000 | ||||
| 2018-10-12 | 2018-10-11 | 4 | Krammer Anja B | BPMX | Common stock | D | 0,1900 | -100.000 | -19 | 2.297.500 | ||||
| 2018-10-12 | 2018-10-10 | 4 | Krammer Anja B | BPMX | Common stock | D | 0,1900 | -102.500 | -19 | 2.397.500 | ||||
| 2018-09-20 | 2018-09-19 | 4 | Tierney David S | BPMX | Common Stock | D | 0,2025 | 100.000 | 20 | 7.500.000 | ||||
| 2018-09-13 | 3 | Tierney David S | BPMX | No securities beneficially owned | D | 0 | ||||||||
| 2018-09-13 | 2018-09-11 | 4 | Tierney David S | BPMX | Option to purchase common stock | D | 0,22 | 0,2200 | 7.400.000 | 1.628 | 7.400.000 | |||
| 2018-09-11 | 2018-09-10 | 4 | Krammer Anja B | BPMX | Option to purchase common stock | D | 0,20 | 1.042.000 | 1.042.000 | |||||
| 2018-03-09 | 2018-03-07 | 4 | Vivo Capital VIII, LLC | BPMX | Common Stock | I | 0,3600 | -2.000.000 | -720 | 16.128.515 | ||||
| 2018-01-31 | 2018-01-30 | 4 | Vivo Capital VIII, LLC | BPMX | Series A Convertible Preferred Stock | I | -1.515 | 0 | ||||||
| 2018-01-31 | 2018-01-30 | 4 | Vivo Capital VIII, LLC | BPMX | Common Stock | I | 4.328.571 | 18.128.515 | ||||||
| 2018-01-09 | 2018-01-08 | 4 | Krammer Anja B | bpmx | Option to purchase common stock | D | 0,11 | 1.960.000 | 1.960.000 | |||||
| 2017-12-22 | 2017-12-20 | 4 | Chan Kin Foong | BPMX | Employee Stock Option (right to buy) | D | 0,20 | 414.000 | 414.000 | |||||
| 2017-12-22 | 2017-12-20 | 4 | Chan Kin Foong | BPMX | Employee Stock Option (right to buy) | D | 0,10 | 900.000 | 900.000 | |||||
| 2017-12-22 | 2017-12-20 | 4 | Hubbard Michael | BPMX | Director Stock Option (right to buy) | D | 0,20 | 205.000 | 205.000 | |||||
| 2017-12-22 | 2017-12-20 | 4 | Hubbard Michael | BPMX | Director Stock Option (right to buy) | D | 0,10 | 450.000 | 450.000 | |||||
| 2017-12-22 | 2017-12-20 | 4 | Kitchener Gregory David | BPMS | Employee Stock Option (right to buy) | D | 0,20 | 414.000 | 414.000 | |||||
| 2017-12-22 | 2017-12-20 | 4 | Kitchener Gregory David | BPMS | Employee Stock Option (right to buy) | D | 0,10 | 900.000 | 900.000 | |||||
| 2017-12-22 | 2017-12-20 | 4 | Krammer Anja B | BPMX | Employee Stock Option (right to buy) | D | 0,10 | 940.000 | 940.000 | |||||
| 2017-12-22 | 2017-12-20 | 4 | Morlock Stephen | BPMX | Director Stock Option (right to buy) | D | 0,20 | 205.000 | 205.000 | |||||
| 2017-12-22 | 2017-12-20 | 4 | Morlock Stephen | BPMX | Director Stock Option (right to buy) | D | 0,10 | 450.000 | 450.000 | |||||
| 2017-11-27 | 2017-11-24 | 4 | Morlock Stephen | bpmx | Warrant to purchase common stock | D | 0,25 | 330.000 | 330.000 | |||||
| 2017-11-27 | 2017-11-24 | 4 | Morlock Stephen | bpmx | Warrant to purchase common stock | D | 0,20 | 330.000 | 330.000 | |||||
| 2017-11-27 | 2017-11-24 | 4 | Morlock Stephen | bpmx | Common stock | D | 0,1500 | 330.000 | 50 | 873.956 | ||||
| 2017-11-13 | 2017-11-09 | 4 | Vivo Capital VIII, LLC | BPMX | Common Stock | I | 0,2000 | -296.394 | -59 | 13.799.944 | ||||
| 2017-08-03 | 2017-08-01 | 4 | FRANKLIN RESOURCES INC | BPMX | Common Stock | I | 0,3372 | 250.000 | 84 | 9.749.615 | ||||
| 2017-05-01 | 2017-04-28 | 4 | Vivo Capital Fund VIII, L.P. | BPMX | Common Stock Warrant (right to buy) | I | 0,90 | 641.026 | 641.026 | |||||
| 2017-05-01 | 2017-04-28 | 4 | Vivo Capital Fund VIII, L.P. | BPMX | Common Stock | I | 0,7800 | 1.282.052 | 1.000 | 14.096.338 | ||||
| 2017-04-19 | 2017-04-18 | 4 | Chan Kin Foong | bpmx | Option to purchase common stock | D | 0,74 | 0,7400 | 435.000 | 322 | 435.000 | |||
| 2017-04-19 | 2017-04-18 | 4 | Kitchener Gregory David | bpmx | Option to purchase common stock | D | 0,74 | 0,7400 | 290.000 | 215 | 290.000 | |||
| 2017-04-19 | 2017-04-18 | 4 | Krammer Anja B | bpmx | Option of purchase common stock | D | 0,74 | 0,7400 | 1.060.000 | 784 | 1.060.000 | |||
| 2017-04-19 | 2017-04-18 | 4 | VONTZ CHARLES GREGORY | bpmx | Option to purchase common stock | D | 0,74 | 0,7400 | 200.000 | 148 | 200.000 | |||
| 2017-04-19 | 2017-04-18 | 4 | Morlock Stephen By Stephen W. Morlock and Karen R. Morlock TTE UDT dated 04/21/03 | bpmx | Option to purchase common stock | I | 0,74 | 0,7400 | 200.000 | 148 | 200.000 | |||
| 2017-04-19 | 2017-04-18 | 4 | Hubbard Michael | bpmx | Option to purchase common stock | D | 0,74 | 0,7400 | 200.000 | 148 | 200.000 | |||
| 2017-01-20 | 3 | VONTZ CHARLES GREGORY | bpmx | No securities beneficially owned | D | 0 | ||||||||
| 2017-01-20 | 2017-01-18 | 4 | VONTZ CHARLES GREGORY | bpmx | Option to purchase common stock | D | 0,45 | 0,4500 | 60.000 | 27 | 60.000 | |||
| 2017-01-20 | 2017-01-18 | 4 | VONTZ CHARLES GREGORY | bpmx | Option to purchase common stock | D | 0,45 | 0,4500 | 65.000 | 29 | 65.000 | |||
| 2016-12-12 | 2016-12-08 | 4 | Krammer Anja B | bpmx | Option to purchase common stock | D | 0,42 | 0,4200 | 400.000 | 168 | 400.000 | |||
| 2016-12-12 | 2016-12-08 | 4 | Chan Kin Foong | bpmx | Option to purchase common stock | D | 0,42 | 0,4200 | 150.000 | 63 | 150.000 | |||
| 2016-12-12 | 2016-12-08 | 4 | Hubbard Michael | bpmx | Option to purchase common stock | D | 0,42 | 0,4200 | 150.000 | 63 | 150.000 | |||
| 2016-12-12 | 2016-12-08 | 4 | Morlock Stephen By Stephen W. Morlock and Karen R. Morlock TTE UDT dated 04/21/03 | bpmx | Option to purchase common stock | I | 0,42 | 0,4200 | 150.000 | 63 | 150.000 | |||
| 2016-12-12 | 2016-12-08 | 4 | Kitchener Gregory David | bpmx | Option to purchase common stock | D | 0,42 | 0,4200 | 175.000 | 74 | 175.000 | |||
| 2016-12-02 | 3 | Vivo Capital VIII, LLC | BPMX | Common Stock | I | 25.628.572 | ||||||||
| 2016-12-02 | 3 | Vivo Capital VIII, LLC | BPMX | Common Stock | I | 25.628.572 | ||||||||
| 2016-11-30 | 2016-11-22 | 4 | FRANKLIN RESOURCES INC | BPMX | Class A Warrants | I | 0,35 | 4.375.000 | 4.375.000 | |||||
| 2016-11-30 | 2016-11-22 | 4 | FRANKLIN RESOURCES INC | BPMX | Common Stock | I | 4.375.000 | 9.499.615 | ||||||
| 2016-11-29 | 2016-11-28 | 4/A | Morlock Stephen | bpmx | Warrants to purchase common stock | D | 0,35 | 321.428 | 321.428 | |||||
| 2016-11-29 | 2016-11-28 | 4/A | Morlock Stephen | bpmx | Common stock | D | 0,3500 | 428.571 | 150 | 543.956 | ||||
| 2016-11-29 | 2016-11-28 | 4 | Morlock Stephen | bpmx | Warrants to purchase common stock | D | 0,35 | 0,3500 | 321.428 | 112 | 496.428 | |||
| 2016-11-29 | 2016-11-28 | 4 | Morlock Stephen By Stephen W. Morlock and Karen R. Morlock TTE UDT dated 04/21/03 | bpmx | Common stock | I | 0 | 251.071 | ||||||
| 2016-11-29 | 2016-11-28 | 4 | Morlock Stephen | bpmx | Common stock | D | 0,3500 | 428.571 | 150 | 543.956 | ||||
| 2016-08-16 | 2016-08-12 | 4 | Morlock Stephen By family trust | bpmx | Common stock | I | 0 | 251.071 | ||||||
| 2016-08-16 | 2016-08-12 | 4 | Morlock Stephen | bpmx | Common stock | D | 0,6500 | 115.385 | 75 | 115.385 | ||||
| 2016-08-16 | 2016-08-15 | 4 | FRANKLIN RESOURCES INC | BPMX | Common Stock | I | 0,6500 | 484.615 | 315 | 5.124.615 | ||||
| 2016-07-25 | 2016-07-21 | 4 | Barbarosh Craig A. | bpmx | Option to purchase common stock | D | 0,62 | 0,6200 | 65.000 | 40 | 175.000 | |||
| 2016-07-25 | 2016-07-21 | 4 | Krammer Anja B | bpmx | Option to purchase common stock | D | 0,62 | 0,6200 | 360.000 | 223 | 465.000 | |||
| 2016-07-25 | 2016-07-21 | 4 | Chan Kin Foong | bpmx | Option to purchase common stock | D | 0,62 | 0,6200 | 170.000 | 105 | 225.000 | |||
| 2016-07-25 | 2016-07-21 | 4 | Hubbard Michael | bpmx | Option to purchase common stock | D | 0,62 | 0,6200 | 65.000 | 40 | 195.000 | |||
| 2016-07-25 | 2016-07-21 | 4 | Morlock Stephen By Stephen W. Morlock and Karen R. Morlock TTE UDT dated 04/21/03 | bpmx | Option to purchase common stock | I | 0,62 | 0,6200 | 65.000 | 40 | 175.000 | |||
| 2016-07-25 | 2016-07-21 | 4 | Kitchener Gregory David | bpmx | Option to purchase common stock | D | 0,62 | 0,6200 | 110.000 | 68 | 400.000 | |||
| 2016-07-06 | 2016-07-01 | 4 | Krammer Anja B | BPMX | Option to purchase common stock | D | 0,65 | 0,6500 | 105.000 | 68 | 105.000 | |||
| 2016-07-06 | 2016-07-01 | 4 | Chan Kin Foong | BPMX | Option to purchase common stock | D | 0,65 | 0,6500 | 55.000 | 36 | 55.000 | |||
| 2016-07-06 | 2016-07-01 | 4 | Kitchener Gregory David | bpmx | Option to purchase common stock | D | 0,65 | 0,6500 | 55.000 | 36 | 290.000 | |||
| 2016-06-14 | 2016-06-13 | 4 | Barbarosh Craig A. | BPMX | Option to purchase common stock | D | 0,76 | 0,7600 | 60.000 | 46 | 110.000 | |||
| 2016-06-14 | 2016-06-13 | 4 | Hubbard Michael | BPMX | Option to purchase common stock | D | 0,76 | 0,7600 | 80.000 | 61 | 130.000 | |||
| 2016-06-14 | 2016-06-13 | 4 | Morlock Stephen By Stephen W. Morlock and Karen R. Morlock TTE UDT dated 04/21/03 | BPMX | Option to purchase common stock | I | 0,76 | 0,7600 | 60.000 | 46 | 110.000 | |||
| 2016-03-31 | 2016-03-29 | 4 | FRANKLIN RESOURCES INC | BPMX | Warrants | I | 1,20 | 270.000 | 270.000 | |||||
| 2016-03-31 | 2016-03-29 | 4 | FRANKLIN RESOURCES INC | BPMX | Common Stock | I | 1,2000 | 540.000 | 648 | 4.640.000 | ||||
| 2016-01-27 | 3 | Barbarosh Craig A. | bpmx | No securities are beneficially owned | D | 0 | ||||||||
| 2016-01-27 | 2016-01-26 | 4 | Barbarosh Craig A. | bpmx | Option to purchase common stock | D | 1,55 | 1,5500 | 50.000 | 78 | 50.000 | |||
| 2016-01-15 | 2016-01-14 | 4 | Morlock Stephen By Stephen W. Morlock and Karen R. Morlock TTE UDT dated 04/21/03 | bpmx | Common stock | I | 1,5300 | 5.500 | 8 | 251.071 | ||||
| 2016-01-15 | 2016-01-13 | 4 | Morlock Stephen By Stephen W. Morlock and Karen R. Morlock TTE UDT dated 04/21/03 | bpmx | Common stock | I | 1,5200 | 6.500 | 10 | 245.571 | ||||
| 2016-01-12 | 2016-01-12 | 4 | Morlock Stephen By Stephen W. Morlock and Karen R. Morlock TTE UDT dated 04/21/03 | bpmx | Common stock | I | 1,6300 | 3.000 | 5 | 239.071 | ||||
| 2016-01-12 | 2016-01-11 | 4 | Morlock Stephen By Stephen W. Morlock and Karen R. Morlock TTE UDT dated 04/21/03 | bpmx | Common stock | I | 1,4300 | 3.000 | 4 | 236.071 | ||||
| 2016-01-11 | 2016-01-07 | 4 | Morlock Stephen By Stephen W. Morlock and Karen R. Morlock TTE UDT dated 04/21/03 | BPMX | Common stock | I | 1,4700 | 5.000 | 7 | 233.071 | ||||
| 2015-12-21 | 3 | FRANKLIN RESOURCES INC | BPMX | Common Stock | I | 8.200.000 | ||||||||
| 2015-12-21 | 3 | FRANKLIN RESOURCES INC | BPMX | Common Stock | I | 8.200.000 | ||||||||
| 2015-10-15 | 2015-10-15 | 4 | Morlock Stephen By Stephen W. Morlock and Karen R. Morlock TTE UPT dated 04/21/03 | bpmx | Common stock | I | 1,2300 | 3.000 | 4 | 228.071 | ||||
| 2015-10-15 | 2015-10-14 | 4 | Morlock Stephen By Stephen W. Morlock and Karen R. Morlock TTE UDT dated 04/21/03 | bpmx | Common stock | I | 1,2500 | 2.000 | 2 | 225.071 | ||||
| 2015-10-13 | 2015-10-09 | 4 | Morlock Stephen | bpmx | Common stock | D | 1,1900 | 2.000 | 2 | 223.071 | ||||
| 2015-10-13 | 2015-10-09 | 4 | Morlock Stephen | bpmx | Common stock | D | 1,2600 | 1.000 | 1 | 221.071 | ||||
| 2015-08-12 | 3 | Kitchener Gregory David | BPMX | No securities are beneficially owned | D | 0 | ||||||||
| 2015-08-12 | 2015-08-10 | 4 | Kitchener Gregory David | BPMX | Option to purchase common stock | D | 1,67 | 1,6700 | 235.000 | 392 | 235.000 | |||
| 2015-07-02 | 3/A | Morlock Stephen By Stephen W. Morlock and Karen R. Morlock TTE UDT dated 04/21/03 | BPMX | Common Stock | I | 204.868 | ||||||||
| 2015-07-02 | 2015-06-30 | 4 | Morlock Stephen By Stephen W. Morlock and Karen R. Morlock TTE UDT dated 04/21/03 | BPMX | Common Stock | I | 1.364 | 220.071 | ||||||
| 2015-06-29 | 2015-06-25 | 4 | Morlock Stephen By Stephen W. Morlock and Karen R. Morlock TTE UDT dated 04/21/03 | BPMX | Series A Convertible Preferred Stock | I | -13.514 | 0 | ||||||
| 2015-06-29 | 2015-06-25 | 4 | Morlock Stephen By Stephen W. Morlock and Karen R. Morlock TTE UDT dated 04/21/03 | BPMX | Common Stock | I | 13.839 | 218.707 | ||||||
| 2015-05-01 | 2015-04-30 | 4 | Hubbard Michael | bpmx | Option to purchase common stock | D | 3,00 | 3,0000 | 50.000 | 150 | 50.000 | |||
| 2015-05-01 | 2015-04-30 | 4 | Morlock Stephen | bpmx | Option to purchase common stock | D | 3,00 | 3,0000 | 50.000 | 150 | 50.000 | |||
| 2015-04-01 | 3 | Morlock Stephen By Stephen W. Morlock and Karen R. Morlock TIEE UPT dated 04/21/03 | BPMX | Common Stock | I | 355.136 | ||||||||
| 2015-04-01 | 3 | Morlock Stephen By Stephen W. Morlock and Karen R. Morlock TIEE UPT dated 04/21/03 | BPMX | Common Stock | I | 355.136 | ||||||||
| 2015-02-13 | 3 | Hubbard Michael | BPMX | No securities are beneficially owned | D | 0 | ||||||||
| 2015-02-09 | 3 | Wang Ping | BPMX | Series A Preferred Stock-No Securities Beneficially Owned | D | 0 | ||||||||
| 2014-02-11 | 3 | Chan Kin Foong | TPND | Common Stock | D | 2.400.000 | ||||||||
| 2014-02-11 | 3 | Chan Kin Foong | TPND | Common Stock | D | 2.400.000 | ||||||||
| 2014-02-04 | 3 | Krammer Anja B | TPND | Common Stock | D | 2.500.000 | ||||||||
| 2014-01-30 | 3 | Pekarsky James | TPND | Common Stock | D | 2.500.000 | ||||||||
| 2013-12-13 | 3 | Thompson Kade | TPND | Common Stock | D | 7.000.000 |
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
